buy custom Signal Transduction in Neuropharmacology essay

buy custom Signal Transduction in Neuropharmacology essay According to Rosenzweig-Lipson, signal transduction is the process by which a cell can convert an input into an appropriate output, such as, the conversion of muscarinic stimulation of glandular tissue into a secretory response (Rosenzweig-Lipson, S. et al 239). In this study we examine the conformational change occurring in the receptor protein which is a consequence of agonistic binding that enables the receptor to interact with a second element in the system. It has been observed that G- protein transduces a signal to a third component an amplifying enzyme that elaborates an additional messenger which is the final component of a system, and activates a cascade of enzymes that leads to an increase in protein phosphorilation and an output or response (Sitaramayya and Ari 8). The membrane of a normal cell acts as a pathway for signals to pass through the intercellular molecules and it is that which activates transcription (Gilman 615649). These signals follow a certain rhythm and thi s series is referred to as signal transduction. Hence in this study, proteins are key components since they play very important roles in various inter-neuronal communications Membrane receptors, Second messengers, and Signal Transduction pathways When the neurotransmitter binds on to the receptor, ion channels permit the flow of ions. The receptors act on the protein channels by using a more indirect second messenger system. This is the G proteins inclusion in the transduction of from the membrane receptors to intercellular effectors. The binding of a neurotransmitter to a receptor activates the G protein this in turn causes the protein channels that gate the ion flow to open and cause migration of either ion. A new component of GPCR signal transduction Proteins are involved in several vital roles in the inter-neuronal communication. The ion channels found in the cell membranes are proteins. G proteins are heterotrimers that consist of three subunits, which include alpha, beta, and gamma (%uF061- (45 to 47 kD), %uF062- (35 kD), and %uF067- (7 to 9 kD). The alpha unit is an active subunit, which binds the guanine diphosphate in its stationary state. On the other hand, it exchanges the guanine diphosphate for the guanine triphosphate when active. During this active mode, it acts as the courier between the receptor sites and the effectors. The other sub units, which include beta and gamma, help the alpha subunit to attach to membranes. Therefore, beta and gamma subunits are deemed as passive units in the G proteins. The alpha unit activates the effectors and gets back to its resting state. The alpha unit returns to its resting state through cleaving the guanine triphosphate, attaching again to the guanine diphosphate, and joining up with the betagamma dimer (Malbon Morris 5). The %uF061-subunit binds GDP or GTP and has an intrinsic, slow GTPase activity. The G%uF061%uF062%uF067 complex in the inactivated state comprises of GDP at the nucleotide site. Binding of hormone to receptor stimulates a rapid exchange of GTP for GDP on G%uF061. When GTP binds, it causes G%uF061 to dissociate from G%uF062%uF067 and to associate with an effector protein like the adenylyl cyclase. Binding of G%uF061 (GTP) activates adenylyl cyclase. The adenylyl cyclase actively synthesizes cAMP as long as G%uF061(GTP) remains bound to it. However, the intrinsic GTPase activity of G%uF061 eventually hydrolyzes GTP to GDP, leading to dissociation of G%uF061(GDP) from adenylyl cyclase and re-association with the G%uF062%uF067 dimer, regenerating the inactive heterotrimeric G%uF061%uF062%uF067 complex. In order to facilitate neuron communication, the post-synaptic neuron should posses the receptor sites for the neurotransmitters discharged from the pre-synaptic neuron. Through binding on to the receptors, the neurotransmitters are expected to facilitate change in the post-synaptic neuron, which may cause a potential action in the post-synaptic neuron. G protein receptors are engaged in numerous diseases. An approximate of 30% of the medicinal drugs target the G protein coupled drugs. The G protein-coupled receptors engage two principal transduction pathways, which include the camp signal pathway and phosphatidylinositol (Malbon Morris 8). A simple process takes place for neuron communication to take place. The postsynaptic neuron must have receptor sites for neurotransmitters that were released by the pre-synaptic neurons. The neurotransmitters must bind on to the receptors hereby bringing about a change in the, post synaptic neuron and this is called an excitatory post synaptic potential or (EPSP). At the same time, it could be an inhibitory post synaptic potential or (IPSP). These two are produced depending on the concentrations of either sodium or chlorine ions existing in the neuron. According to Jeong, the change in concentration happens in the channeling of either sodium or chlorine ions that migration across the cell membrane (Jeong Ikeda pp. 335347). The neurotransmitter-receptor binding facilitates the opening of the protein channels. The receptor is sited on the top of the protein channel to simplify the opening of the protein channels. The neurotransmitter-receptor binding enables the protein channel to allow the ion flow. The protein channels can also be acted upon by the receptors in an indirect fashion through a second messenger system. The second messenger system is exemplified by a G proteins addition in the transduction of signals from the transmembrane receptors to intracellular effectors. Clearly, the neurotransmitter-receptor binding stimulates the G protein, which facilitates the opening of the protein channels for ion flow (Sitaramayya and Ari, 23). In a second messenger system, a ligand binds to a receptor while the G protein attaches to the receptor. The guanine diphosphate that is bound to the alpha unit is replaced by the guanine triphosphate thus the unit detaches from the rest of the G protein. In this process, the next session differs from the simple messenger system. The alpha unit fails to attach to a protein channel and instead binds to another membrane protein known as adenylyl cyclase. The Adenylyl cyclase converts adenosine triphosphate to cyclic monophosphate. The process is initiated after the alpha unit latches on to adenylyl cyclase. Furthermore, the cyclic adenosine monophosphate initiates another protein in the neuron known as protein kinease. Protein kinease is a component that is composed of two elements, which include regulatory unit and catalytic unit. Commonly, the regulatory unit scrutinizes the catalytic unit. The cyclic adenosine monophosphate, however, causes the two units to detach. The catalytic un it, which is the active component moves to the protein channels in the membrane of the ion and triggers them to open. The ion flow finally occurs and the excitatory post-synaptic potential or inhibitory post-synaptic potential are stimulated. Several second messenger systems similarly work effectively. Proteins: transducers of receptor-generated signals The G protein initiates a series of changes in the neuron and the ion channels open up. A receptor encounters a G protein in its active state. It is clear that the receptors and the G proteins are pre-coupled. The signal transduction relies on the form of the G protein. Adenylate cyclase enzyme is a type of a cellular protein that is regulated by the G protein. The activation of the Adenylate cyclase enzyme terminates when the G protein gets to the guanine diphosphate bound state. The Adenylate cyclases can also be activated in other methods, which regulate their activity. The heterotrimeric G proteins can engage in functional roles independent of the G proteins-coupled receptors. Apart from the heterotrimeric G proteins, other types of G proteins also play vital roles in the cell function. These proteins belong to a certain group known as small G proteins. They also perform their activities like the heterotrimeric G proteins. A G protein coupled receptor is a receptor that mediates the opening of the ion channels through a G protein. This component is involved in a system that renovates the external signals into an intracellular second messenger system. In this second messenger system, the neurotransmitter binds on to a receptor while the G protein attaches on to the receptor and becomes triggered. The alpha subunit, then binds on to the protein ion channel and cause it to open thus permitting ion flow. Therefore, signal transfer in this case is the vital role for the G protein. The function of G protein in the other version of the second messenger system is less undeviating. In this case, it does not activate the protein channels in the membrane. It activates a series of events that cause the opening of protein channels. This constitutes about seven membrane domains interconnected by three intercellular domains and three extracellular loops, an extra cellular N-terminal domain and an intracellular C- terminal domain. Each of the seven interconnected domains is composed of about 20- 27 amino acids. The GPRS span three environments and these are extracellular, intra-membrane as well as the intra-cellular. The conformal change of the central core will be responsible for the conformation of the intracellular loops and this will activate the binding and processes of the G protein. The activation of these proteins is then responsible for the activation of various intracellular signaling pathways. G protein-coupled receptors (GPCRs) have been identified to be the target for more than half of the drugs currently on the market; this includes approximately 25% of the 100 top-selling drugs. Hence, they are considered the most important molecules in drug discovery, due to their role as receptors in many processe s in the body and their presence in all the body tissues. G-protein specificity The binding of the GPCR to some of the different proteins will determine the various inter-membrane and intracellular members resulting in the localizing of the receptors and the G protein independent signaling (Hildebrandt Iyengar, 4). These proteins include the tyrosine protein kinesis and scaffolding proteins. GPCRs can be classified according to five groups. These five families are classified according to their phylo-genetic origins. They are glutamate, rhodopsin, frizzled, adhesive, and secretin and these form the GRAFS classification system. The rhodopsin family makes up the largest portion and was formerly named as family one or family A. It has the largest number of receptors in the group and 700 members. The group has some similarities of phylogenetic characteristics, but also has some intrinsic characteristics. There are about four more classifications from the rhodopsin group. There are three classes of adrenergic receptors of the super family of G- protein coupled receptors and they mediate a large variety of peripheral as well as the central responses to the endogenous catecholamines. All of the adreno-receptor subfamilies are comprised of three receptor subtypes that that are categorized by a distinct heterotrimeric G protein coupling. One concept that shares characteristics with inverse agonism is that of protean agonism. In this way, some ligands display both characteristics of both agonism and inverse agonism in a single GPCR. This event is quite rare and has only been observed at a handful of GPCRs and is not well understood at the present, however, it provides some notion into how the ligands modulate the GPCR behavior. In normal theorem, any preparation that is used in the measurement of GPCR stimulation by agonists can also may be used to study the inhibitory effects that come about from inverse agonism. This is because both groups of agonists and inverse agonists produce their effects from balancing or modulating the active as well as the inactive receptors. However, there should be an amount of spontaneous receptor activity needed to measure individual effects of either class of ligand. Similarly, the detection of inverse agonism requires that spontaneous receptor activity be quite distinguishable from that of background noise. This according to experience will not be the actual case. The measuring of inverse agonism and its effects intrinsically is quite difficult. The conditions for doing the same therefore will be the same as by measuring the receptor activation from the agonists. When a ligand is found to have a negative effect on an agonist, independent GPCR then the one carrying out the experiment must find out if it is genuine. The presence of endogenous activating ligands also needs to be ruled out of the equation. If that is not possible then one need to demonstrate the effects of a strong inverse those of the neutral antagonists or weak inverse agonists overshadow agonists. At the same time, the confusing effects of the related receptor subtypes if any are present at the time should be considered. There is a differential set for G protein partners, which allow it to initiate different signaling pathways in order to trigger diverse and even opposed functional outcomes in response to the same stimuli. The distribution of tissue according to the different adrenal receptor subtypes varies quite differently while conferring to the different catelochamines (Ciruela 31). G protein coupled receptors can activate G proteins and initiate the signaling in the presence of the agonist. The receptor activity can be quite spontaneous but can be regulated by certain antagonists. A process that many refer to as inverse agonism causes this and the inverse agonists job is to produce biochemical effects that are opposite to the agonists. This will dispute with the theorem that many support as to state the antagonists lack intrinsic activity. This would suggest their work is to preclude the binding of agonists to the receptors solely. The work of inverse agonism has been displayed in a wide variet y of systems. These include endogenously and heterogeneously expressed GPCRs. On the other hand, the contribution of inverse agonism to the overall therapeutic effects of antagonism is hard to etermine considering the continual presence of the endogenous agonists in the normal physiological conditions that are set in the state. However, the proof to such evidence of awaits the confirmation and evidence that spontaneous receptor signaling is significant or it changes in terms of receptor density or distribution. These have to be attributable to the effects of inverse agonism at the cellular and the sub cellular level. These also occur in intact organisms Thus, inverse agonism can be assessed at the level of the receptor, the G protein, and the effector as well as the effects that follow downstream. When considering the technique that works best in this issue it might depend on the system that is currently under investigation. Mall of the ends in this case, may not necessarily yield the equivalent results that many expect thus, it would be worthwhile trying to assign the ligand activity to multiple levels. The receptor, however, facilitates binding of the inverse agonists which increases by the guanine nucleotides whereas the agonists have an opposite reaction of decreased binding. Receptor-dependent specificity The past decade has seen many events whereby cell surface carbohydrates play a role in signal transduction events. This was hypothesized some time ago that the complex structure of cell surface carbohydrates was there to play an informational role (Haltiwanger 593). The numerous developmentally relevant pathways are affected by proteoglycans as well as the recent importance demonstrations of fucose modifications in notch and nodal signaling. This suggests that the time for uncovering the involvement of the glycans in signaling is just beginning. Many other proteins are involved in developmental or signaling events that are predicted to go through modification with O-fucose. At the same time, the EGF sites are also modified at consensus sites between the first as well as the second conserved cysteines. Many of the predicted O-glucose sites on the notch receptor have conservation because of evolution. This proposes that the modifications will play an important role in notch signaling. The other important form of O-fucose is mapped on to the consensus site on the thrombospondin type 1 repeats. However, this type repeats on a heparan-sulfate-binding domain and that suggests that the alteration may activate reactions at the site. These results and progress suggests that the surface has hardly been scratched the surface in terms of the role of glycosolation in the regulation of signal transduction. The objective is to find a link between these factors and the brain in neuropharmacology. Thus, we must become fully aware of what it means. Neuropharmacology is study of drugs that interact with neurons in the brain and this affects the mood, sensation, thinking and overall behavior. There are some of these alterations in behavior that result from drug intake but not all. RGS proteins as drug target GPCRs are excellent targets for pharmaceutical treatments since they comprise of the most widely screened classes of signal transduction targets (Auld, et al., 2002). Major diseases involve the malfunction of the receptors; hence they become the most important drug target for pharmacological intervention. Thus, changes result in the actions of the brains chemical transmitters, which is under the field of brain neuro-chemistry. A lot of interest is coming to the fore over molecular neuroscience in both clinical as well as basic research. This is because of new findings on topics such as neuro-peptides, neuro-hormones that have been disseminated into a number of topics that keeps on increasing with the time. The topic focuses on new drugs that will be used in neurology which some consider as the final frontier of the medical world. The aim is to also modify the processes of the brain on the premise of improving on some characteristics. These include memory; mood as well as attention de ficits that people may have and give enhancements in these sectors. However, they would not be impaired by disease or illness beforehand thus; it would cause much debate on the ethical field. There is also a field dedicated to this known as neuro-ethics. This field is defined as the study of legal and social questions that arise when scientific study and discoveries of the brains processes come into the medical field in practice. The problem in the real essence lies with the organ. It is the brain, which we are dealing with and it is responsible for making all of us unique in our own individual way. This gives us our personalitys emotions, memories emotions, dreams, and creative abilities, (Neuro-ethics 1). Therefore, it is the driving force behind the motives of our individual actions. Many out there would support the medical development of the sector of neuroscience in order to help deal with mental illness as well as basic research to further our understanding. However, they would rather the journey end there, as they are not too comfortable with getting to know too much about the human brain. The human brain is a special piece of art and holds a special place because it gives everyone his or her own autonomy. Manipulating this organ is not the same as operating and altering another part of the body like the lungs, kidney, or the heart. It is because of its sensitive nature that not too many people would be thrilled about giving stimulating drugs to alter intelligence of mood set up. This would be manipulating a persons character and would cause many uncomfortable feelings. Enhancement at this stage is not confined to neuroscience but there is a sense that something is quite distinct about enhancing things to do with cognitive functions as well as behavior. RGS inhibitors as clinical therapeutics Neural disorders for one have their origin in form of shifts and delicate balances in the neuro-chemicals that could originate from cell damage of degeneration. However, the brain is quite flexible and capable of restoration of certain imbalances. This can be done by increasing the sensitivity of the brain to a certain neuro-transmitter. However, this is not to say that it cannot also fail. When a substance such as dopamine is depleted, especially when talking about Parkinsons disease, then a disease or severe neural disorder may come, as a result. The fundamental research in neuropharmacology investigates the processes going on the brain and how drugs introduced to that system interact with those processes. One of the research tools that many like to employ is the building models of the neuro-chemical as well as the neuro-physiological processes. These aim to fit the data on the laboratory studies on the animal models. In a certain pharmacy department in a university, this happened by electrophysiological and microdyalisis methods in order to track the nerve signals. Nerves propagate their electric signals by conducting an electric pulse and this is known as an action potential. Endogenous RGS-protein function The signal in turn activates release of some transmitter chemicals at the terminals of the cell that affect the receptors of the next nerve cell in the relay that in turn continues the cycle. On the other hand, placing an electrode inside the brain will allow the individual to monitor further electrical activity. The release of the transmitters will be monitored while using the micro dialysis probe. This probe would also be used to release these chemicals locally and measure the full effects. At the pharmacy department at this university, neuro-physiological pathways are studied using two techniques. The specific studies that occur when relating several variables together that gives an understanding of the function of the brain area. To give a basic visual description of the neural circuits, bow and arrow models can be drawn that represent negative and positive influence relations. These models will be further tested for their correct nature and in this way, used to explain the functioning of this system. In this way, newly developed drug compounds will give a foothold in this sector because they will play the role of revising and refining the model as well as the experiments that are conducted. The model in turn will play the role of getting to know the effects. This would be in such a way , that if a drug used were to selectively favor one particular type of pathway then, it could still be used to further explore the function of that pathway. The data acquired from this may serve to refine the model and in this way, the effects may be explained as well as predicted. At this university, there is a group of nuclei called the base ganglia. These nuclei play an all-important role in the control of voluntary behavior. Scope of review in Parkinsons disease In Parkinsons disease a portion of them that do not survive decay due to a cause that yet remains unknown. However, this portion is a supplier of an important neuro-transmitter called dopamine. This transmitter is postulated to perform a modulating function. It is also thought to create a delicate balance in the signals that are bound for the cortex. In order for this to work, however, a schematic model should be used to represent neural activity in the brain ganglia especially according to Parkinsons disease. If this were visually illustrated on a paper, an arrow would serve as a neural pathway. This would consist of a bundle of individual nerve cells. The box in this case, would represent the nucleus or a clustering of nerve cells. The model gives a dual function to dopamine. It shows a direct path from the striatum to the SNR while inhibiting the indirect path via the STN. The balance creates an inhibition in two fronts, which are the thalamus and the brainstem. However, when it becomes nearly depleted then the balance becomes disrupted once again and this results in the increase of activation in an area known as the SNR. This state of hyper-activation in this region causes inhibition of brainstem neurons, which go hand in hand with some symptoms of Parkinsons disease. Most of the traditional research that goes to Parkinsons disease focuses on restoring levels of dopamine in the brain. However, the compound cannot be administered as an oral substitute because it cannot go through the blood brain barrier. On the other hand, it was found that L-dopa could pass through the barrier and it metabolizes while in the brain to form Dopamine. Thus, at the present it is the most successful method of dealing with Parkinsons symptoms. Possible clinical uses of RGS inhibitors Similarly administering L-dopa to the brain raises dopamine levels in other parts of the body. This high concentration of dopamine in the body on the other hand, causes feelings of nausea as a side effect. This is due to stimulation of dopamine receptors in other parts of the body. The therapeutic effect however, declines over a period like three to five years. Further research into the issue is finding out the effects of highly selective dopamine receptors that interact with certain dopamine receptors. The functions of the brain are quite dynamic. In neuro-biology, it is described as complex dynamic system. In physics the tools that people use for modeling dynamic systems is by employing differential equations. The variables show the properties of the system. This variables change over the course of time. When the relationship between those variables is ascertained then one can get the value of these values and thus, one can see the original state of the system. Therefore, empirical study of both the brain and the behavior of Parkinsons research will result in correlating variables of the activation frequency of the nuclei as well as the neural pathways and local concentrations of different types on neurotransmitters. RGSG interaction site the A-site (mark Herlitze (Eur. J. Biochem) However, these relations are not enough to dub the equation as quantitative thus; the relation is only seen as qualitative. There are many results on study on the brain whereby the change of one variable in one direction would cause another variable to be perceived as moving in another direction, as a result. Here the theory would explain why in Parkinsons disease, the activation of the thalamus decreases with the decrease of concentration of DA in the striatum (Peijnenburg 351). In the event that these events are insufficient to provide a model with the help of an ordinary differential equation, they can still be represented by a more abstract qualitative equation. G protein signaling in the C Until the recent past, it was thought that synaptic transmission was conceptualized some processes where the neurotransmitters would act through their receptors and cause changes in conductances of certain ion channels to cause excitatory or inhibitions on the postsynaptic potential. If taken in this view the human brain would seem to be a very complex diagram whereby the complexity of the visual representation would be in the complex wiring. It has become quite evident over the past twenty years that neurotransmitters elicit complicated effects on the neurons that serve as their targets. This led to a better and complete understanding of synaptic transmission. In addition to the fast elicitation of the post synaptic potentials and the neuro-transmitter receptor interactions influence most of the activities of the target neuron through a complicated network of intracellular messenger systems. The activation of most catecholamine receptors and most of the other types of receptors is transmitted to the intracellular sites via the G proteins. These in turn couple the receptors to other effector proteins. These would include the numerous intracellular second messenger pathways as well as the ion channels. The generation of these second messengers leads to various physiological effects courtesy to their arrival. In most of the cases, the intracellular cascades would involve the changes that occur in protein phosphporylation. This would be the removal of protein phosphatases from the target phosphoproteins or the addition happening through protein kinases. The altered phosphorylation of the phosphoproteins could also be considered as a third messenger. This also alters the physiological nature and activity. This happens with all of the neurotransmitters. Catelochamine regulation of the second messenger and the protein pathways influence a big part of the neuron function through the phosphorylation of different types of the neural proteins. These types of intracellular processes produce some sort of quick response to the neurotransmitter and this can be regulation of the ion channel or neuronal firing rate (Ross Wilkie, 795827). At the same time, these processes may produce a short-term modulatory effect on the neuronal function such as the regulation of the response of the neuron relating to similar or different neurotransmitters. These changes can also cause long-term modulation effects on the functioning of the neuron and this can be expressed through gene expression regulation. These changes would require altered synthesis of receptors as well as ion channels, cellular proteins and other forms of learning. There may be an exception of synaptic transmission that is mediated through receptors containing intrinsic enzyme activity or ion channels. The family of the trans-membrane could be involved in signaling in the nervous system. The G proteins get their name from their ability to bind with guanine nucleotides, which are guanine diphosphate and triphosphate as termed earlier. Since more and more is becoming known in the field, additional information is being revealed on certain materials otherwise thought to be dormant. Zinc for one, has long been thought to be a mere static component of the protein family. It was thought to only provide catalytic or structural functions to the group. There is recent research that indicates there is a further use for the metal, especially a particular type known as an intracellular pool of labile zinc, in signal transduction. The homeostasis process of zinc is under tight control, whereby, a specialized system of transport proteins regulates the entry and the export through the plasma membrane and through intracellular distribution. While in the cell, zinc can be stored in the vesicles. These are called zincosomes and the regulation on the labile zinc in the plasma is observed (Wu et al 1q31.). There are several reports that describe the fluctuations of labile zinc happening after the stimulation of cells on several established pathways. These include mitogen activated protein kinases and calcium that has been showing up. The important point is that is has been discovered that labile zinc is essential for well-known and established physiological signals. The investigations of the molecular mechanism of how zinc exerts the effects have come to identify that it directly reacts with the several components of signaling the pathways, which include the interleukin receptor associated kinase 1. These observations conclude that zinc is a second bivalent metal ion. Actions of the ANS on the cardiovascular system It also has the function as the second messenger in the cardiovascular system. In any case, it would seem that signal transduction is the key. The term first made the mark in biological literature in the seventies. It appeared as a title word as early as 1979. Most [physical scientists and electronic engineers had earlier used the term to conversion of energy or information from one form to another. An example being that a microphone transduces sound waves to electric signals. However, attention went to the biological application and the GTP and GTP binding proteins in the metabolic regulation. The term was borrowed from other fields to describe its role. The use of the term grew in momentum and by the year, 2000 about 12 percent of all of the papers that used the word cell had mentions of the word transduction. In the main issue when considering signal transduction, there is concern about the external influences and this could mean the presence of specific hormones and how they coul d affect what happens inside the target cells. There is some difficulty however, since the hormones being hydrophilic meaning the substances are unable to pass through. Thus, their influence is exerted from the outside and the membranes of the cells are very thin, and effectively impermeable to ions as well as polar molecules. Even foe small molecules such as urea, the permeability is still about ten thousand times lower than that of water. Thus for a molecule like that of adrenaline the permeation is still quite too low to measure. Thus, the evolution of these receptors has accompanied the development of the mechanisms and it is these, which permit the external chemical signaling molecules. These are the first messengers to direct the activities within the cells in many ways with high specificity. Signal transduction has delved into the world of the intracellular activities as those within the cell. There should also be a consideration of the adherence of the cell surface to other cells and enquires how this works in terms of asking how it affects the responses to the soluble agonists such as growth factors as well as the how the soluble agonists a ffect the cellular adherence. The event itself is an important in the maintenance of the stem cell compartments as well as the epithelial mesenchymal transition. These molecules affect the adhesion and therefore serve as the targets for the signals that are generated within the cell (Zhong Neubig, pp. 837845). These are two exemplified aspects in regulation of survival, regulation as well as leukocyte trafficking. Adhesion molecules are very important especially when it comes to the nerve cell differentiation, functioning of the synapse as well as gene expression in the epithelial cells. At first, these adhesive molecules were thought to be a form of glue but this turned out to be an untruth. At the present, they are recognized as receptors and the act as signaling molecules. However, the ligands that are involved with these adhesion molecules are insoluble. They are presented themselves on the adjacent cells by an extracellular matrix that happens to be on the surface of epithelia, or by a mass of connective tissue. These adhesive molecules development became known in the 1970s as a result of an investigation interestingly about the brain. It was realized that the organizational system of the cells that were in the central nervous system needed a systematic and dynamic process of cell gui dance as well as cell adhesion. This would go on to drive the direction seeking processes of neutrite growth and the formation of synapses. On this account, there were two main ideas that were considered. One was suggested during the development in order to establish precise cell-to-cell contacts. The interacting cells would each present the adequate unique adhesion molecules that would fit into each other like a lock and key simulation. The second idea would be that the set of adhesion molecules would be limited although their building capacity is limited over time. For instance, one could say that offering the same molecule during the process of outgrowth. This would be interpreted as a low affinity state. The cell would then turn to convert the adhesion molecule into a high affinity state. This might help in binding to a counter part in a nearby cell. It appears that there is truth to both of the propositions. The number of the adhesion molecules is limited and their capacity to interact with the counter receptors is regulated at the levels of expression and by their state of binding. In the part of immunology, the set of adhesion molecules that is set on the cell surface as well as the state of activation is dubbed as the area code (De Vries et al, pp 235-271). Some chemicals in the brain assist with the functions of releasing the synapses with the neurotransmitters. Neuro-peptides are released at the synapse region along with the neurotransmitters. They differ from the neurotransmitters in the fact that they are found at lower concentrations and are derived from larger inactive molecules that would be precursors, synthesized in the soma. These neuro-peptide precursors are transported down the axon while they are in the process of getting processed and cleaved. They are then degraded right after the synaptic release. The precursor peptides can then be processed differently according to the different neurons. They can act as multiple sites whereby they include the pre synaptic and post synaptic sites this could then include cells that are far away from their site of release. Peptide release however, requires calcium. The quantity of the release in this case is proportional to the neuronal firing. Most of the peptide binding sites are G- prot ein coupled receptors that activate enzyme effectors or ion channels. Many psychoactive drugs alter the neuronal signaling by acting as endogenous transmitters to activate neurotransmitter receptors. The other drugs act by altering synthesizing the release, uptake, or degradation of a neurotransmitter. The chronic use of psychotropic drugs exerts the common effects through the regulation of neuronal signaling elements that would occur at a variety of levels. These include the neurotransmitters, G proteins, second messengers, as well as the protein kinases. Chronic drug agonist treatment introduces the down regulation of the receptors by reducing the receptor synthesis that takes place (Hammer and Kaplan, 59). Other drugs such as anti psychotics may produce effects at a variety of levels, which include genomic, neuro-chemical, as well as neuro-physiological. At this, level the acute treatment antipsychotic treatment of the dopaminmergic neurons. On the other hand, chronic antipsychotic drug treatment produces the delayed inactivation of dopamine neuron firing. The condition of the brain and the reactions to different drugs affect whether one would be an addict or not. For one, neurosomatic patients do not fit the criteria for addiction prone people. This is in the same way, that chronic pain patients are not prone to addictions. Drug abuse in terms of medicine would be termed as craving higher amounts and doses of drugs that would cause acute damage to the patient upon intake (Goldstein, 331). Some chronic pain patients would argue their dosage requires escalation on a regular basis; however, they still hold to the line. These individuals are the ones at risk and have the most cases, of dropping from counseling. The sensitization of behavior encompasses the ability of stimulated cells NAc cells to secrete peptides as well as related substances. Signal transducing pathways may also include the regulation of alternative splicing. In this way, the use of alternative exons keeps changing during the development or in response to other stimuli. Neurons can change their molecular structure when they become activated, (Chen Lambert, 2000). This can be done by communication with other neurons or by receiving information from the outside. In the basic definition of the sense, a drug is a substance that brings about a biological change within the functions of a cell. The agonist, in this case, binds to and activates the receptor. The agonists come in various forms whereby a full agonist binds and activates the receptor with full efficiency. A good example in this case, of a full agonist is isoproterenol and its mimics the ligand epinephrine. Other drugs act as pharmaceutical antagonists. They might bind the receptors but do not lead to any signaling by the cell. On the contrary, they interfere with the ability of an agonist to activate the receptor. In this case, the effect of a pure or neutral antagonist depends entirely on it preventing the binding of the agonist molecules and blocking their biological functions. An endogenous ligand like serotonin may bind and stimulate the receptors that couple to different subsets of the G proteins. It is becoming apparent that the relative efficacy of compounds may actually depen d on the conditions used in the experiment. Inverse agonists on the other hand, are easier to identify with functional screens versus classical binding essays. When a receptor lacks the constitutive activity, a neutral agonist in turn acts as the neutral competitive agonist (Chan Otte, pp. 10-20). This was emphasized by a recent report where it was thought to be the neutral antagonists of the 5HT, which were shown to be the inverse agonists. Future prospects The regulations of signal transduction within critical regions of the brain have effects on the intracellular signal generated by multiple neurotransmitter systems. The effects represent putative mediators of the therapeutic actions of the available antidepressants and mood stabilizers, mediated by their effects on a network of interconnected neurotransmitter pathways. For many refractory patients with brain disorders, new drugs that resemble the "traditional" drugs that alter neurotransmitter levels either directly or indirectly and those that bind to cell surface receptors which are of little medical importance (Arshavsky Pugh, pp. 11-14). This happens so because of the assumption that the target receptors are functionally intact, furthermore the altered synaptic activity will be transduced to modify the postsynaptic "throughput" of the system. However, abnormalities existing in signal transduction pathways suggest that improved refractory to conventional medications is obtained b y direct targeting of postreceptor sites. Discoveries on a variety of mechanisms involved in the formation and inactivation of second messengers allows for development of pharmacological agents designed to "site-specifically" target signal transduction pathways. However, this is more complex than the development of receptor-specific drugs. This has made it possible to design novel agents that may have implications on the second messenger systems due to their heterogeneous nature at the molecular and cellular level linked to receptors in various ways and expressed in different cell types in different stoichiometries. Furthermore, since signal transduction pathways show unique characteristics depending on the rate of guanine nucleotide exchange, G protein conformational states, GTP hydrolysis, interaction with different RGS proteins, and cytosol-to-membrane translocation of PKC isozymes and receptor kinases, and many other ways, they provide in built-in targets for relative specificity of action, that relies on the "set point" of the substrate. In this study, we can summarize that due to technological advances in both biochemistry and molecular biology, understanding the complexities of the regulation of neuronal function is greatly enhanced in our abilities. Buy custom Signal Transduction in Neuropharmacology essay

Health Priorities in Australia Essay Example | Topics and Well Written Essays - 1500 words

Health Priorities in Australia - Essay Example These areas may have a level of overlap within the six priority areas which have been defined therefore it is important to understand these areas on their own before the priority overlaps between them can be discussed. The NHPA (National Health Priority Areas) themselves were created as a response to global agenda put forward by the WHO (World Health Organisation) which was to focus on those areas which make up the majority of patient cases around the world (Browne et. al., 2000). The priority areas for Australian health are overseen by the National Health Priority Action Council (NHPAC) that is made up of commonwealth, state, regional as well as local governments (AIHW, 2005). There are two primary objectives the NHPAC looks at before considering any health related problem as a priority areas. First, the NHPAC examines whether making a health issue a priority objective could significantly contribute towards lessening the burden of illness and injury on Australians. Second, the NHPAC sees if the area to be focused on will improve health related issues and if it will decrease the burden on our health system which is due to the diseases included in the priority area (AIHW, 2005). It is important to note that the NHPA did not start with the seven priority areas mentioned above because it shows that the NHPA is not a static body. Rather, like other scientific organisations, it is looking towards expanding itself and improving its position through active research and analysis which shows how the addition of a priority area can be beneficial for public health. Historically speaking, the NHPA initiative began with only four areas i.e. cardiovascular health, cancer control, injury prevention and mental health (AIHW, 2005). With time, Diabetes was added to the priority areas in 1997 with asthma being added in 1999 and musculoskeletal issues being added in 2002. It is clear that the government is not picking diseases randomly from the

Values and Ethics Research Paper Example | Topics and Well Written Essays - 2000 words

Values and Ethics - Research Paper Example My personal mission statement is: to achieve a successful career as an ‘Emergency Medical Technician’ by following my personal ethical values and the professional ethics observed in the organization and the profession as a whole. It is apparent from my mission statement that I seek to pursue a successful career on the basis of my ethical values. I attach significant importance to the ethical values as they form the foundation for a successful career or a successful organization. Along with following my own ethical values through my career, I would also follow the ethical values observed in the profession as a whole and in the organization that I would be a part of. Ethical values hold a very important role in the success of an organization therefore in my career I would opt for organizations that hold strong ethical values and the ethical values that are appropriate in conformity with the overall profession. My personal ethical values that would guide me as a future manager include; professional behavior, objectivity, integrity, accountability, innovativeness, cooperation, encouragement, fairness, equality, and confidentiality. Professional behavior would help me put my best efforts in my career by working sincerely. Professional behavior would also help me conduct the tasks in my professional capacity in a better way. Objectivity means having an unprejudiced opinion and not being biased while making a professional decision. As a manager, objectivity would help me make decisions that are best for the organization as a whole and I would not be influenced by any factors that may impair my objectivity. Integrity would help me conduct my job without any immoral or fraudulent acts. Accountability means being responsible for all the acts conducted in the professional capacity. Due to accountability, I would be responsible for my acts as a manager. Because of being responsible, I would try to conduct my tasks in the best way possible. Therefore, accountability

Hog Waste in Eastern North Carolina Essay Example | Topics and Well Written Essays - 1500 words

Hog Waste in Eastern North Carolina - Essay Example It also says in Proverbs 11:22, "Like a gold ring in a swine's snout is a beautiful woman without discretion." The swine is just another animal with all the instincts and emotions of fear, anger, contentment or hunger. But the scriptures appear to depict the animal's dispositions that include habits other than just chewing cuds. The swine is known to eat more than cuds. They consume anything from garbage including dead animals and human waste. Thus, the swine is categorized with animals that are not "clean". They cannot be counted among animals like the sheep, goat, deer, and so on that consume only grass and herbs and are categorized as "clean" (Douglas S. Winnail). From the Christian perspectives, the hog is associated with meanness and laziness. The points expressed in the scriptures about the hog do little to dissociate it from such negative attributes. Once the hog has had its fill with food it normally resigned to a corner to slumber the rest of its time. God made all things wonderful and this includes the swine. The swine or hog is not meant for human consumption from its natural standpoint. In the present times, hog meat can be neutralized from the effects of salmonella through vaccinations (Jeffrey A. Husa et al). However, in the times when the Old Testament injunction for not eating the hog was made, the scriptures emphasized that as people of God to serve as a model for the nations around them, the Israelites were to abstain from hog meat for its specific dietary habits. The hog could eat anything. It was not restricted to chewing cuds alone. By the same argument, the hog could also do many things that did not make it an ideal choice for culinary purposes. The hog could grunt, struggle violently, bite, kick and heave. The hog did not observe the basic niceties when it was about to be killed. This contrasted with the disposition of animals like the sheep and goats that did not have to be trussed up when they were slaughtered. What does the theological tradition say about this problem (This will require doing library research in books on theological ethics Theological tradition is varied. There is no single view. Some theologians say that the law about not eating the hog does not apply now. They hold to the scriptures when Apostle Peter was famished and had a vision of "a great sheet let down by four corners upon the earth. In it were all kinds of animals and reptiles and birds of the air. And there came a voice to him, 'Rise, Peter; kill and eat.' But Peter said, 'No, Lord; for I have never eaten anything that is common or unclean'. And the voice came to him again a second time, 'What God has cleansed, you must not call common (or unclean)'" (Acts 10:11-15). There is yet another theological tradi

County Backs Plan for Inland Port in the Glades Essay Example for Free

County Backs Plan for Inland Port in the Glades Essay The commissioners in Palm Beach County found the need to support the construction of an inland port because it would give employment opportunities for the locals. Summary: A vote of 5-2 was the result of the discussion among Palm Beach County commissioners favoring the development of an inland port in the area. They believe that this would help the locals obtain more jobs that are within the county, which means easier access and less wasting of time travelling from one place to the other. Locals do not have to commute to other nearby cities for their jobs and lose precious family time. Also, this plan would help develop the county in economic terms. Analysis: While many people came to the commission chambers to support the plan, there were also activists who disliked the idea due to environmental reasons. It was very difficult to determine whose side had a better argument because the other has the welfare of the locals in mind while the other tries to defend nature and the fact that people should not just develop land over the glades. There were no words from the water district officials but the â€Å"activists said that Florida Crystals’ land sits in the middle of a potential pathway for restoration, which could recreate the historic flow of water from the lake to the Everglades† (Sorentrue â€Å"County Backs Plan for Inland Port in the Glades†). Conclusion: Although both sides had strong arguments as to whether or not the inland port should be constructed, it should be pointed out that the welfare of the people should be put first. The inland port would not take over the whole of Everglades and if environmental procedures were done properly so as to do no or at least minimal harm on nature, then it will be a win-win situation. The commissioners should make sure that they do not agree to this because it would bring them money but that they agree to this because it is what the people need. They also have to ensure that they do minimal damage to nature while developing the land.

Distinguishing Panavision And Bensusan :: Legal Essays

Distinguishing Panavision And Bensusan The law regarding jurisdiction determination was far from crystal clear even before the internet came of age, and courts are now having a difficult time reconciling the "purposeful availment" and related "effects" tests used in traditional jurisdiction analyses with the new paradigms in information transfer made possible by the internet, and in particular by the World Wide Web (WWW). These difficulties are apparent in Panavision, Int'l. L.P. v. Toeppen, 938 F. Supp 616 (C.D. Cal. 1996), and Bensusan Restaurant Corp. v. King, 937 F. Supp. 295 (S.D.N.Y. 1996). Both cases involved trademark infringement and dilution suits stemming from the alleged use of the trademark on the WWW. Each court came down differently on the jurisdiction issue, and rightly so, but neither court's analysis was very satisfying when one attempts to distinguish the two cases. In Toeppen, the defendant had formed a plan to find prominent registered trademarks which had not yet been registered as internet addresses, and register them as his own, with the expectation that he could sell them at a substantial profit to the owner of each mark should that owner desire to do business on the internet using that internet address. The court used a three-part test for specific jurisdiction, the first part of which was the "purposeful availment" test, which in turn became an "effects test" when the claim is in the nature of a tort. After deciding that the claim was tort-like, the court used the "effects test" and found that Toeppen's acts were 1) intentional, 2) aimed at California, and 3) caused foreseeable harm to the plaintiff. This was at the heart of the court's reasoning in exercising jurisdiction. The facts in Bensusan start out very much like Toeppen, but diverge at a point, resulting in a decision to decline to exercise jurisdiction. In Bensusan, which proceeded Toeppen by ten days, the defendant, a Missouri jazz club, had set up a web page the contents of which contained an allegedly infringing use of the plaintiff's trademark, "The Blue Note". The plaintiff, owner of the mark for a New York jazz club, wanted the New York district court to interpret state law so that it could exercise jurisdiction over the Missouri club. It refused to do so because, under a similar "effects test" to that used in Toeppen (the court here also found the claim to be in the nature of a tort), there was no foreseeable harm to the plaintiff.

Promoting Brand Loyalty at Abercrombie & Fitch Essay

Abercrombie and Fitch is an American retailer that focuses on casual wear for consumers aged 18 to 22. It has over 300 locations in the United States, and is expanding internationally. The company also operates three offshoot brands: Abercrombie, Hollister Co., and Gilly Hicks. The company operated a post-collegiate brand, Ruehl No.925, that closed in early 2010. The company operates 1,073 stores across all four brands. The A&F brand has 316 locations in the United States, four in Canada, one in London, one in Milan, one in Tokyo, one in Copenhagen, one in Madrid, one in Paris, one in Brussels, one in Dublin, and one in Hong Kong. A&F stores range from 6,000 to 36,000 square feet. The company focuses on providing high-quality merchandise that compliments the casual classic American lifestyle. selling casual sportswear apparel, including knit and woven shirts, graphic t-shirts, fleece, jeans and woven pants, shorts, sweaters, outerwear, personal care products and accessories for men, women and kids under the Abercrombie & Fitch, abercrombie kids, and Hollister brands. The Company determines its operating segments on the same basis that it uses to evaluate performance internally. The operating segments identified by the Company are Abercrombie & Fitch, abercrombie kids, Hollister and Gilly Hicks. The operating segments have been aggregated and are reported as one reportable segment because they have similar economic characteristics and meet the required aggregation criteria. The Company believes its operating segments may be aggregated for financial reporting purposes because they are similar in each of the following areas: class of consumer, economic characteristics, nature of products, nature of production processes, and distribution methods. The Company views the customer’s in-store experience as the primary vehicle for communicating the spirit of each brand. The Company emphasizes the senses of sight, sound, smell, touch and energy by utilizing visual presentation of merchandise, in-store marketing, music, fragrances, rich fabrics and it s sales associates to reinforce the aspirational lifestyles represented by the brands. The Company considers the in-store experience to be its main form of marketing. The Company emphasizes the senses to reinforce the aspirational lifestyles represented by the brands. The Company’s flagship stores represent the pinnacle of the Company’s in-store  branding efforts. The Company also engages its customers through social media and mobile commerce in ways that reinforce the aspirational lifestyle of the brands. Flagship stores and social media both attract a substantial number of international consumers, and have significantly contributed to the Company’s worldwide status as an iconic brand. The in-store marketing is designed to convey the principal elements and personality of each brand. The store design, furniture, fixtures and music are all carefully planned and coordinated to create a shopping experience that reflects the Abercrombie & Fitch, abercrombie kids, Hollister or Gilly Hicks lifestyle. The Company’s sales associates and managers are a central element in creating the atmosphere of the stores. In addition to providing a high level of customer service, sales associates and managers reflect the casual, energetic and aspirational attitude of the brands. Every brand displays merchandise uniformly to ensure a consistent store experience, regardless of location. Store managers receive detailed plans designating fixture and merchandise placement to ensure coordinated execution of the Company-wide merchandising strategy. In addition, standardization of each brand’s store design and merchandise presentation enables the Company to open new stores efficiently. The Company had net sales of $2.929 billion for the fifty-two weeks ended January 30, 2010, down 15.9% from $3.484 billion for the fifty-two weeks ended January 31, 2009. Operating income for Fiscal 2009 was $117.9 million, which was down from $498.3 million in Fiscal 2008. Net income from continuing operations was $79.0 million and net income per diluted share from continuing operations was $0.89 in Fiscal 2009, compared to net income from continuing operations of $308.2 million and net income per diluted share from continuing operations of $3.45 in Fiscal 2008. Net income per diluted share from continuing operations included non-cash, store-related asset impairment charges of $0.23 and $0.06 for Fiscal 2009 and Fiscal 2008, respectively. Net cash provided by operating activities, the Company’s primary source of liquidity, was $402.2 million for Fiscal 2009. This source of cash was primarily driven by results from operations adjusted for non-cash items including depreciation and amortization and impairment charges. The Company used $175.5 million of cash for capital expenditures and had proceeds from the sale of marketable securities of $77.5 million during Fiscal 2009. The Company’s Market Share may be  Adversely Impacted at any Time by a Significant Number of Competitors. The sale of apparel and personal care products is a highly competitive business with numerous participants, including individual and chain fashion specialty stores, as well as regional and national department stores. The Company faces a variety of competitive challenges, including maintaining favorable brand recognition and effectively marketing its products to consumers in several diverse demographic markets. And sourcing merchandise efficiently and countering the aggressive promotional activities of many of the Company’s competitors without diminishing the aspirational nature of the Company’s brands and brand equity. There can be no assurance that the Company will be able to compete successfully in the future. The science of the Deal Ch.7 Genentech is a biotechnology corporation, founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert Boyer.   Today, Genentech has the biggest market capitalization in biotech at US $88 billion, with an incredible reputation in drug development, especially in oncology, and a number of blockbuster drugs under its belt. Genentech has multiple products on the market for serious or life-threatening medical conditions. In March 2009, Genentech became a member of the Roche Group, and Genentech now serves as the headquarters for all Roche pharmaceutical operations in the United States. Accordingly, the list below includes products which were previously marketed as Roche products that are now being marketed by Genentech in the United States. Genentech’s relationship with Roche Holding began in 1990, when the Swiss company bought a 60 percent stake in Genentech for $2.1 billion. As a result of additional stock purchases and sell offs, Roche owned about 56perce nt of Genentech in 2008. The success of Genentech as a biotechnology company is indeed in no small part derived from its strategy of forming alliances with smaller companies, whose proprietary drugs and technology platforms have the potential to become blockbusters. The commercialized drug, called Tarceva, is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other  types of cancer, which was released in 2004 and quickly acquired blockbuster status. It is marketed in the United States by Genentech and OSI Pharmaceuticals and elsewhere by Roche. In lung cancer, it extends life by an average of 3.3 months at a cost of CDN$95,000. Historically, this approach has brought Genentech great rewards, particularly in the field of oncology, and now the company is hoping to achieve similar success in new therapeutic areas. To support small companies with promising technologies and/or drugs in development that are at too early a stage for licensing. In this way, Genentech has developed a highly competitive approach, singling out small companies with enormous future potential and establishing mutually beneficial relationships at the earliest possible stage. A significant proportion of the Genentech pipeline has always consisted of proprietary technology platforms and drug candidates, and its brave approach to R&D spending reflects this. In 2003, 24% of Genentech’s revenues were directed into R&D, to address the top-heavy position of its pipeline at the time. To balance resource use with the strongest likelihood of success, Genentech continuously evaluates its pipeline products in order to determine which are the most promising projects to move through the many phases of clinical testing. The pipeline includes both breakthrough innovations and new indications for existing, well understood products that may fight more than one disease or more than one form of a disease.